Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting ...

Johnson & Johnson JNJ is one of the few large drug and medical device companies with a presence in both the pharmaceuticals ...

Suryakumar Yadav surprised fans with a health update on Wednesday, June 25. From a Munich hospital bed, SYK shared an ...

Stryker just received FDA clearance for its Incompass® Total Ankle System, reinforcing its drive for surgical innovation and ...

Stryker stock is trading -6.87% below its average target price of $421.46 after marking a 1.6% during today's afternoon ...

This was the stock's fourth consecutive day of gains.

Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the ...

Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.

Gross margins declined to 66.4% in the first quarter from 67.6% a year ago due to increased depreciation, a higher mix of ...

New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its ...

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi ...

This has positioned BSX as the second-largest player globally, largely due to the rapid adoption of pulsed field ablation ...